Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Furazidin
2. Solafur
1. Furazidin
2. 1672-88-4
3. Furazidine
4. Akritoin
5. Furaginum
6. 1-((3-(5-nitro-2-furyl)allylidene)amino)hydantoin
7. 1-[(e)-[(e)-3-(5-nitrofuran-2-yl)prop-2-enylidene]amino]imidazolidine-2,4-dione
8. K2r4n34y9i
9. Nf 416
10. F-35
11. 1-((3-(5-nitro-2-furyl)allylidene)amino)-hydantoin
12. 1-[(e)-[(z)-3-(5-nitrofuran-2-yl)prop-2-enylidene]amino]imidazolidine-2,4-dione
13. Furamag
14. 1-((3-(5-nitrofuran-2-yl)allylidene)-amino)imidazolidine-2,4-dione
15. 1-(((1e,2e)-3-(5-nitrofuran-2-yl)allylidene)amino)imidazolidine-2,4-dione
16. 1-{[(1e,2e)-3-(5-nitrofuran-2-yl)prop-2-en-1-ylidene]amino}imidazolidine-2,4-dione
17. Ccris 1199
18. 1-(3-(5-nitro-2-furyl)-n-2-propenylidine)amino-hydantoin
19. Brn 0307076
20. Unii-k2r4n34y9i
21. Furagin (tn)
22. Furazidin [mart.]
23. Furazidin [who-dd]
24. 1-[3-(5-nitro-2-furyl)allylidenamino]hydantoin
25. 4-24-00-01048 (beilstein Handbook Reference)
26. Schembl3194895
27. Chembl3707254
28. Hydantoin, 1-((3-(5-nitro-2-furyl)allylidene)amino)-
29. Schembl17292896
30. J01xe03
31. Dtxsid101030908
32. Ex-a1974
33. Bdbm50549808
34. S3709
35. Stk368597
36. Zinc31430194
37. 1-((3-(5-nitro-2-furanyl)-2-propenylidene)amino)-4-imidazolidinedione
38. 2,4-imidazolidinedione, 1-((3-(5-nitro-2-furanyl)-2-propenylidene)amino)-
39. Akos005444359
40. Ccg-267084
41. Cs-0798
42. Db13475
43. Bs-49182
44. Hy-77036
45. D07998
46. 672f884
47. A810846
48. 1-(3-(5-nitro-2-furyl)-n-2-propenylidine)aminohydantoin
49. 1-(((e)-3-(5-nitrofuran-2-yl)prop-2-enylidene)amino)imidazolidine-2,4-dione
50. 2,4-imidazolidinedione, 1-[[3-(5-nitro-2-furanyl)-2-propen-1-ylidene]amino]-
Molecular Weight | 264.19 g/mol |
---|---|
Molecular Formula | C10H8N4O5 |
XLogP3 | 0.5 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 3 |
Exact Mass | 264.04946937 g/mol |
Monoisotopic Mass | 264.04946937 g/mol |
Topological Polar Surface Area | 121 Ų |
Heavy Atom Count | 19 |
Formal Charge | 0 |
Complexity | 455 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 2 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Infective Agents, Urinary
Substances capable of killing agents causing urinary tract infections or of preventing them from spreading. (See all compounds classified as Anti-Infective Agents, Urinary.)
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01X - Other antibacterials
J01XE - Nitrofuran derivatives
J01XE03 - Furazidin
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Market Place
ANALYTICAL
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?